Covaxin Gets WHO approval for Emergency Use

Covaxin vaccine was reviewed by WHO’s Strategic Advisory Group of Experts on Immunization (SAGE), and recommended use of this vaccine in two doses, with a dose interval of four weeks, in all age groups 18 and above.

Bharat Biotech’s Covaxin has been added to the approved list of Covid-19 vaccines by World Health Organization (WHO).

WHO on Wednesday approved the ‘made-in-India’ vaccine as emergency use listing (ELU) cleared for use for 18+ years an above.

Following the indigenous vaccine approval, WHO said that the Technical Advisory Group, convened by WHO and made up of regulatory experts from around the world, has determined that the Covaxin vaccine meets WHO standards for protection against Covid-19 that the benefit of the vaccine far outweighs risks & the vaccine can be used

WHO further said that Covaxin vaccine was reviewed by WHO’s Strategic Advisory Group of Experts on Immunization (SAGE), and recommended use of this vaccine in two doses, with a dose interval of four weeks, in all age groups 18 and above.

The global health body also said, “Available data on vaccination of pregnant women with Covaxin are insufficient to assess vaccine safety or efficacy in pregnancy; studies in pregnant women are planned, including a pregnancy sub-study and a pregnancy registry.”

Ads 003 1
- Advertisement -

For more such stories, follow us on Facebook, Twitter, and Instagram. Download our Android App. Subscribe to our Website Notifications to stay updated.

Also Read

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Advertisement
Ads 002

Connect With Us

10,219FansLike
321FollowersFollow

Latest

Support Us